Farmal

Varazdin, Croatia Founded: 1959 • Age: 67 yrs Acquired By Dermapharm
RD company focused on manufacturing generic drugs for multiple therapeutic areas

About Farmal

Farmal is a Healthcare company based in Varazdin (Croatia) founded in 1959, and was acquired by Dermapharm in February 2011. RD company focused on manufacturing generic drugs for multiple therapeutic areas. Its chief executive, as recorded, is Drazen Dedi. Its focus areas include Diversified Pharmaceuticals.

Company details

Farmal was established in 1959 in Varazdin, Croatia, as a research and development entity in the pharmaceutical sector. Generic drugs are produced for various therapeutic areas, with operations centered on formulation and manufacturing processes. The company maintains its headquarters in Croatia, serving regional and international markets through standardized production of affordable medications. Leadership is provided by CEO Drazen Dedi, overseeing core activities in drug development and quality control.

Key Metrics

Investors in Farmal

Farmal has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Dermapharm.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Dermatological and pharmaceutical medications are developed and manufactured.
1991dermapharm.deGrunwald, Germany
Premium access

Investor details for Farmal

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Farmal

1 people are tracked at Farmal (1 in leadership).

NameRoleGroup
Drazen Dedi
CEOLeadership
Premium access

Complete people profiles for Farmal

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Farmal

2 dated milestones of Farmal across 52 years, from founding to its latest funding, stage changes and deals.

  1. Founded Farmal is founded.
  2. Exit Acquired by Dermapharm.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Farmal

Farmal was founded in 1959.

Farmal is headquartered in Varazdin, Croatia. It is registered at Varazdin, Varazdin County, Croatia.

Drazen Dedi is the CEO of Farmal, as recorded in our data.

Farmal was established in 1959 in Varazdin, Croatia, as a research and development entity in the pharmaceutical sector. Generic drugs are produced for various therapeutic areas, with operations centered on formulation and manufacturing processes. The company maintains its headquarters in Croatia, serving regional and international markets through standardized production of affordable medications. Leadership is provided by CEO Drazen Dedi, overseeing core activities in drug development and quality control.

Farmal has 1 investor. Key investors include Dermapharm.

Yes. Farmal was acquired by Dermapharm in February 2011.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available